Document Detail


Rare pediatric non-hodgkin lymphoma.
MedLine Citation:
PMID:  20490722     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Of the cases of non-Hodgkin lymphoma (NHL) diagnosed in children and adolescents, 10% comprise a diverse mixture of unusual B-cell or T-cell disease, some types of which are more commonly seen in adults. Understanding of these rare types of NHL comes from small pediatric case series or the adult literature. Some rare pediatric NHL is similar to adult NHL, but other types have different molecular and cytogenetic characteristics. It is important to improve understanding and treatment of these rare pediatric NHLs through international collaborative efforts.
Authors:
Bhuvana A Setty; Amanda M Termuhlen
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current hematologic malignancy reports     Volume:  5     ISSN:  1558-822X     ISO Abbreviation:  Curr Hematol Malig Rep     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-07     Completed Date:  2010-09-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101262565     Medline TA:  Curr Hematol Malig Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  163-8     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Nationwide Children's Hospital, Division of Hematology/Oncology/BMT, 700 Children's Drive, Columbus, OH 43205, USA. Bhuvana.Setty@nationwidechildrens.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Child
Humans
Lymphoma, B-Cell / diagnosis,  therapy
Lymphoma, B-Cell, Marginal Zone / diagnosis,  therapy
Lymphoma, Follicular / diagnosis,  therapy
Lymphoma, Non-Hodgkin / diagnosis,  therapy*
Lymphoma, T-Cell, Peripheral / diagnosis,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyperbaric Oxygen in the Management of Chronic Diabetic Foot Ulcers.
Next Document:  Does Rituximab Have a Place in Treating Classic Hodgkin Lymphoma?